These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 16381954)

  • 21. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis.
    Cheng AM; Byrom MW; Shelton J; Ford LP
    Nucleic Acids Res; 2005; 33(4):1290-7. PubMed ID: 15741182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TargetFinder: a software for antisense oligonucleotide target site selection based on MAST and secondary structures of target mRNA.
    Bo X; Wang S
    Bioinformatics; 2005 Apr; 21(8):1401-2. PubMed ID: 15598838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiled support vector machines for antisense oligonucleotide efficacy prediction.
    Camps-Valls G; Chalk AM; Serrano-López AJ; Martín-Guerrero JD; Sonnhammer EL
    BMC Bioinformatics; 2004 Sep; 5():135. PubMed ID: 15383156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the efficacy of short oligonucleotides in antisense and RNAi experiments with boosted genetic programming.
    Saetrom P
    Bioinformatics; 2004 Nov; 20(17):3055-63. PubMed ID: 15201190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approaches for the sequence-specific knockdown of mRNA.
    Scherer LJ; Rossi JJ
    Nat Biotechnol; 2003 Dec; 21(12):1457-65. PubMed ID: 14647331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thermodynamic criteria for high hit rate antisense oligonucleotide design.
    Matveeva OV; Mathews DH; Tsodikov AD; Shabalina SA; Gesteland RF; Atkins JF; Freier SM
    Nucleic Acids Res; 2003 Sep; 31(17):4989-94. PubMed ID: 12930948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mRNA accessible site tagging (MAST): a novel high throughput method for selecting effective antisense oligonucleotides.
    Zhang HY; Mao J; Zhou D; Xu Y; Thonberg H; Liang Z; Wahlestedt C
    Nucleic Acids Res; 2003 Jul; 31(14):e72. PubMed ID: 12853649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mfold web server for nucleic acid folding and hybridization prediction.
    Zuker M
    Nucleic Acids Res; 2003 Jul; 31(13):3406-15. PubMed ID: 12824337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense technologies. Improvement through novel chemical modifications.
    Kurreck J
    Eur J Biochem; 2003 Apr; 270(8):1628-44. PubMed ID: 12694176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational antisense oligo prediction with a neural network model.
    Chalk AM; Sonnhammer EL
    Bioinformatics; 2002 Dec; 18(12):1567-75. PubMed ID: 12490440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisense therapy for cancer--the time of truth.
    Jansen B; Zangemeister-Wittke U
    Lancet Oncol; 2002 Nov; 3(11):672-83. PubMed ID: 12424069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial neural network prediction of antisense oligodeoxynucleotide activity.
    Giddings MC; Shah AA; Freier S; Atkins JF; Gesteland RF; Matveeva OV
    Nucleic Acids Res; 2002 Oct; 30(19):4295-304. PubMed ID: 12364609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concepts to automate the theoretical design of effective antisense oligonucleotides.
    Far RK; Nedbal W; Sczakiel G
    Bioinformatics; 2001 Nov; 17(11):1058-61. PubMed ID: 11724735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antisense therapeutics: lessons from early clinical trials.
    Flaherty KT; Stevenson JP; O'Dwyer PJ
    Curr Opin Oncol; 2001 Nov; 13(6):499-505. PubMed ID: 11673691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase.
    Allawi HT; Dong F; Ip HS; Neri BP; Lyamichev VI
    RNA; 2001 Feb; 7(2):314-27. PubMed ID: 11233988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical prediction of single-stranded regions in RNA secondary structure and application to predicting effective antisense target sites and beyond.
    Ding Y; Lawrence CE
    Nucleic Acids Res; 2001 Mar; 29(5):1034-46. PubMed ID: 11222752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ODNBase--a web database for antisense oligonucleotide effectiveness studies. Oligodeoxynucleotides.
    Giddings MC; Matveeva OV; Atkins JF; Gesteland RF
    Bioinformatics; 2000 Sep; 16(9):843-4. PubMed ID: 11108708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selecting optimal antisense reagents.
    Sohail M; Southern EM
    Adv Drug Deliv Rev; 2000 Oct; 44(1):23-34. PubMed ID: 11035195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of sequence motifs in oligonucleotides whose presence is correlated with antisense activity.
    Matveeva OV; Tsodikov AD; Giddings M; Freier SM; Wyatt JR; Spiridonov AN; Shabalina SA; Gesteland RF; Atkins JF
    Nucleic Acids Res; 2000 Aug; 28(15):2862-5. PubMed ID: 10908347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of RNA secondary structure on cellular antisense activity.
    Vickers TA; Wyatt JR; Freier SM
    Nucleic Acids Res; 2000 Mar; 28(6):1340-7. PubMed ID: 10684928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.